The rise and fall of rofecoxib and valdecoxib demonstrate the need for caution in new drug development
Rheuminations: Ankylosing Spondylitis Sometimes Defies Detection
How method of diagnosing, treating this inflammatory back disease characterized by stiffness and the presence of HLA-B27 gene has evolved
Mobile Health Devices May Have Limited Use in Rheumatology
Challenges exist in developing m-health apps for rheumatology patients because of the difficulty in pinpointing what needs to be measured
How Rheumatism Got its Name
The origination of the ailing word and its variations throughout history used to describe rheumatic disorders
Rheuminations: Road to Success in Medicine May Be Paved with Failure
How healthcare has benefited from breakthrough discoveries related to bovine spongiform encephalitis, H. pylori ulcer disease, and properdin by researchers who persevered despite criticism from skeptics
Rheuminations: Why the Obesity Epidemic Should Matter to Rheumatologists
As changes in diet and eating habits have caused obesity rates to soar, research into the metabolic syndrome suggests obesity may be a form of a low-grade inflammatory state
Rheuminations: Rheumatologists Seek Better Understanding of Fibrosing Disorders
Research into scleroderma, fibrosis, and Raynaud’s phenomenon may provide clues into the pathogenesis of systemic sclerosis
John F. Kennedy’s Odyssey in Search of Diagnosis
Myriad health conditions from back pain to gastrointestinal illness plagued the late president and baffled his physicians
Rheuminations: The Power of the Placebo
Can rheumatologists harness the placebo effect to improve patient care?
Rheuminations: How Disruptive Technology Has Transformed the Medical School Classroom
iPads, social media, and massive, open online classes have changed the way we teach
- « Previous Page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- …
- 23
- Next Page »